News
Royal Society honours Dal oceanographer for globally recognized climate research
Enhancing the ocean’s capacity to absorb carbon dioxide emissions is part of Dal oceanographer Dr. Katja Fennel’s groundbreaking research. This week, the Royal Society of Canada recognized Dr. Fennel’s contributions by naming her in the 2026 Class of Fellows. Read more.
Featured News
Tuesday, September 8, 2026
As it enters a new era, the MacEachen Institute of Public Policy and Governance is expanding its efforts to connect researchers, decision-makers, and communities on pressing national and regional issues.
Tuesday, September 1, 2026
As he begins his term as dean, Dr. Saleem Razack discusses social accountability, medical education, and his vision for strengthening health care across the Maritimes and beyond.
Wednesday, September 2, 2026
Designed around real-world challenges facing firefighters, the program supports professional growth and helps enhance emergency response capacity in communities throughout Nova Scotia.
Archives - News
Friday, September 30, 2016
Dalhousie’s annual Mawio'mi event on Thursday, October 6 will be preceded by the permanent installation of the Mi’kmaq flag on Dal’s Studley Campus.
Tuesday, September 27, 2016
Last week the Dal-hosted MacEachen Institute for Public Policy and Governance welcomed several former parliamentarians to campus to meet with students and discuss various topics, including oceans, Nova Scotia’s economic future and careers in public policy.
Thursday, September 22, 2016
Nursing research trailblazer Linda O’Brien-Pallas, architectural innovator Glenn Murcutt and ocean advocate Zdenka Willis will be receiving honorary degrees at Fall Convocation ceremonies on October 3 and 5.
Friday, September 16, 2016
Last week, Dal’s science community shed light on the incredible biodiversity found on the university’s urban campus with a unique sort of scavenger hunt.
Tuesday, September 13, 2016
Atlantic Canada Opportunities Agency announces $3 million in funding to support Dr. Chris McMaster and his team in developing drug treatments for what are known as "orphan" or rare childhood diseases that impact thousands of Canadians.